Cingulate Inc. business relationships
Companies named in Cingulate Inc.’s 10-K filed 2026-03-18, and public companies whose annual reports name Cingulate Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 4.2 / 10
- AI naming
- <1 / 100 Top 36% in its category
- Agent readiness
- 20 / 100
- AI adoption
- 0 / 100
Named in Cingulate Inc.’s annual report 4
“We also intend to partner with IQVIA, pursuant to a Licensing and Services Master Agreement, in the commercialization of CTx-1301,” SEC filing
“in good faith any changes to the services provided by IQVIA due to changes in circumstances or priorities established by us.” SEC filing
“March 2023, we entered into a joint commercialization agreement with Indegene, Inc. ("Indegene") to partner in the commercialization” SEC filing
“entered into a patent and know-how licensing agreement with BDD Pharma Limited in August 2018.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.